Leibniz Research Network

Stem cells and organoids

The Leibniz Research Network "Stem cells and organoids" serves the methodological-technological exchange on stem cells and their application in the research areas represented by the network partners.

Björn von Eyss is instrumental for the FLI’s involvement in this research network. The molecular biologist uses stem cells to decipher the epigenetic and transcriptional changes that lead to a loss of function of these cells. The goal is to identify and functionally define causal processes that could serve as future targets for therapies that enable healthier aging.


Leibniz Institute of Aging Research – Fritz Lipmann Institute (FLI)

Bioactive compounds

The research on bioactive compounds deals with the discovery, extraction, production, and improvement as well as the application and analysis of active substances in humans, animals, plants, and the environment, including research into modes of action and systemic effects.

Clara Correia-Melo works together with Robert Rennert (IPB Halle) on the identification of plant and fungi-derived natural bioactive compounds with senolytic and or senostatic properties with therapeutic potential.

Collaboration partners

Leibniz Institute of Aging Research – Fritz Lipmann Institute (FLI)

Leibniz Institute of Plant Biochemistry (IPB) Halle


Björn von Eyss
+49 3641 65-6047

More information: www.leibniz-gemeinschaft.de


Clara Correia-Melo
+49 3641 65-6323

More information: www.leibniz-wirkstoffe.de